Short Term Effect of Glucocorticoids on Brown Adipose Tissue Thermogenesis in Humans
NCT03269747 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2019-06-05
Summary
Interventional, Placebo controlled cross-over study to investigate the short-term effects of glucocorticoids (prednisone) on human brown adipose tissue.
Conditions
- Brown Adipose Tissue
Interventions
- DRUG
-
2 tablets of Prednisone 20 Mg in the morning
- DRUG
-
2 Placebo tablets in the morning
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Matthias J Betz, MD · University Hospital, Basel, Switzerland
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-12-06
- Primary Completion
- 2019-04-16
- Completion
- 2019-04-16
Countries
- Switzerland
Study Locations
More Related Trials
-
Microvascular Dilatation After Endogenous Induced Hyperinsulinemia
NCT00742456 ·Status: COMPLETED ·Phase: NA
-
Metformin to Prevent Metabolic Complications in Glucocorticoid Excess
NCT01187849 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans
NCT06333496 ·Status: COMPLETED ·Phase: NA
-
Intranasal Glucagon and Energy Balance
NCT03650582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Obese Human Beta-2-adrenergic Stimulation and Muscle Glucose Uptake
NCT04921306 ·Status: COMPLETED ·Phase: PHASE2
-
Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.
NCT01232244 ·Status: COMPLETED
-
Incretin Physiology Associated With Steroid Hormone Treatment
NCT00713440 ·Status: COMPLETED ·Phase: NA
-
Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure
NCT00264199 ·Status: COMPLETED ·Phase: NA
-
Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
NCT04687514 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
NCT05598008 ·Status: COMPLETED
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Ghrelin Decreases Insulin Sensitivity
NCT00512525 ·Status: COMPLETED ·Phase: PHASE1
-
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
NCT03204396 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects
NCT00822003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.
NCT03444467 ·Status: COMPLETED ·Phase: PHASE1
-
B-type Natriuretic Peptide and Glucose Metabolism
NCT01324739 ·Status: COMPLETED ·Phase: NA
-
Boosting the Secretion of GLP-2 and GLP-1 Intestinal Hormones by Nutrients
NCT01727583 ·Status: COMPLETED ·Phase: NA
-
Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans
NCT01900340 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake
NCT03141632 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
NCT02001363 ·Status: UNKNOWN ·Phase: NA
-
Effect of Intranasal Insulin on Cognitive Processes and Appetite
NCT03632681 ·Status: COMPLETED ·Phase: NA
-
Leptin to Treat Severe Insulin Resistance - Pilot Study
NCT00027456 ·Status: COMPLETED ·Phase: PHASE2
-
Neuronostatin - a Glucagonotropic Agent in Humans?
NCT06143267 ·Status: COMPLETED ·Phase: NA
-
Renal and Hormonal Effects of Pioglitazone
NCT01090752 ·Status: COMPLETED ·Phase: PHASE4
-
To Determine Tolerability to Glucagon Infusion in Obese Subjects
NCT02817659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1